A $35.8 million fair value charge on Canopy USA assets buried an otherwise real growth quarter, pushing the loss per share to triple consensus. International cannabis revenue jumped 141% on German and Polish medical demand. The CFO still sees positive adjusted EBITDA in fiscal 2027.
Latest Activity
CGC Coverage
Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease
A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company’s following moved the wrong way. Tilray Brands shares are at $3.56, down…
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here’s Why TLRY Is Still Down 47% YTD
Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched.
Cannabis’s 280E Tax Trap May Finally Break. We’ve Heard That Before.
Cannabis investors have watched rescheduling euphoria ignite and incinerate capital at least four times since 2018, and a fresh DEA hearing is now on the calendar. The question is whether this cycle…
Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to Schedule…
Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Official Confirmation
Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday. The catalyst is growing speculation…
Stock Market Live December 15: S&P 500 (SPY) Could Test 7,600 in 2026
Live Updates Insiders are Buying One of the Market’s Worst Performing Stocks1:24pm ETIt’s always a good idea to keep an eye on insider buying. After all, it’s the insiders who know their…
Trump Lights Up the Cannabis Market With Plans for Reclassification
The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like…
Cannabis Stocks Are Roaring 20% Higher This Morning. Here’s Why
It wasn’t that long ago that cannabis stocks promised explosive growth after Canada legalized recreational marijuana in 2018 and U.S. states accelerated reforms. Investors poured billions into the sector, envisioning a booming…
Pot Stocks Plunge After Rally: Is Betting on Rescheduling Worth the Risk?
From Hype to Hiccups in the Cannabis Craze Once hailed as the “next big thing,” cannabis stocks in 2018-2019 were the artificial intelligence stock darlings of their day, riding a wave of…
Will a Change to US Marijuana Policy Save Any of the Weed Companies?
The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug.
Earnings Previews: AbbVie, Cameco, Canopy Growth, PepsiCo, Under Armour
Before U.S. markets open on Thursday, AbbVie, Cameco, Canopy Growth, PepsiCo and Under Armour will report quarterly earnings.
Earnings Previews: Canopy Growth, DR Horton, Hecla Mining
Here is our preview of three companies set to report quarterly earnings before markets open on Wednesday.
Thursday’s Top Analyst Upgrades and Downgrades: Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton, Snowflake, SoFi and More
Thursday's top analyst upgrades and downgrades included BioCryst Pharmaceutical, Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton Interactive, Snowflake, SoFi Technologies, XPO Logistics and Zoominfo Technologies.
Big Tech Disappointments: Analysts Upgrade or Downgrade Canopy Growth, Roku and Others
Wednesday’s additional top analyst upgrades and downgrades were on Ally Financial, Baker Hughes, Biohaven, Biogen, Bumble, Canopy Growth, Corning, Discover Financial Services, Match, Roku and more.
Weed Stocks Soar on Biden Pardon, Promised Review
President Biden on Thursday pardoned people who had been convicted of federal charges of simple possession of marijuana, sending pot stocks soaring. But strong headwinds remain for the industry.